New first-in-class datasets will improve the capabilities of state of the art protein AI models to create new biologic drugs DAVIS, Calif.--(BUSINESS WIRE)--The OpenFold group, a non-profit artificial ...
A successful drug discovery and development pipeline involves a wide variety of data, including molecular and macromolecular structures, in vivo and in vitro bioactivity, bioavailability, ...
In the region, the definition of “high-risk drug use”/“problem drug use” is limited to “current injecting drug use” due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback